Clinical context
Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.
What was studied
Aphakia or dislocation of an IOL–capsular-bag complex requires optical reconstruction without normal capsule support. This narrative review maps anterior- and posterior-segment approaches, iris fixation, middle-segment surgery and early artificial-capsule technology. Practice has shifted from anterior-chamber lenses toward posterior-chamber fixation as small-gauge vitrectomy, suture materials, sutureless scleral methods and purpose-built IOLs evolved. It is a clinical review, not a meta-analysis with one pooled effect.
How the evidence was produced
A review can assemble clinical context and explain how an approach fits among alternatives. Unlike a randomized trial or formal meta-analysis, it usually does not provide an independent quantitative effect estimate and is more dependent on author selection of the literature. Conclusions should be checked against the cited primary studies and current guidance.
How to interpret the result
The review favors anatomy-based selection over ranking one operation. Endothelium, chamber depth, iris, sclera, vitreoretinal status, available IOL and team expertise all matter. Similar mean acuity can conceal differences in refractive predictability, tilt, dislocation, macular edema, glaucoma and revision complexity. Artificial capsules may restore bag-like support and broaden optic choice, but are not established standard care.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.
Limitations
This is an expert narrative review rather than a preregistered systematic search, so literature selection may be incomplete. Comparisons rely on heterogeneous retrospective series with different indications, devices, techniques and follow-up. Certainty for rare late events is limited and artificial-capsule experience is early. Verify search methods, direct-comparison quality, conflicts, device models, follow-up and separation of evidence from expert interpretation in the source.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.